Traditional IRA
Rollover IRA
Roth IRA


Expert Advice
Simple Plan
Keogh Plan
401K Plan
SEP Plan


LEAPS
Mutual Funds
Long-Term Picks
Covered Calls
Weekly Wrap


Interactive Charts
Bookstore
Chat Room


About Us
Advertise
Contact Us
Disclaimer
Terms of Service
 
IRAinvestor.com 02/18/2001

IRA Investing > Covered Calls In association with
By Mark Wnetrzak

Looking for a Stage 1 base or Earnings Excitement?

Covered Call Legend:
LB-Last Bid price
OI-Open Interest
CB-Cost Basis or break-even point
DE-Days to Expiry
MR-Monthly Return.

GLGC - Gene Logic $23.94 *** Stage I Base ***

Gene Logic (NASDAQ:GLGC) provides products and services in the areas of gene expression information, data management and bio-informatic software, and pharma-cogenomics. These products and services are all designed to improve the efficiency and effectiveness of the drug discovery and development process. They may also be applied to research and development in other sectors, such as diagnostics, animal health, and agriculture.

The company's information products combine software tools with large-scale gene expression information, which specifies the degree to which genes are active in a broad range of normal, diseased, and treated conditions. This combination enables scientists to produce new biological knowledge by integrating this proprietary expression information with a growing array of biological information available on the Internet. Gene Logic has moved back into its trading range from $20 to $26 and it continues to forge a Stage I base. Earnings are due Tuesday.


MAR 20.00 CYV-CD LB=4.88 OI=3 CB=19.06 DE=28 MR=5.4% 


ANSR - Answerthink $8.09 *** Earnings were the Answer! ***

Answerthink (NASDAQ:ANSR) is a leading provider of technology- enabled business transformation solutions. The Company brings together multi-disciplinary expertise in benchmarking and research, business transformation, interactive marketing, business applications and technology integration to serve the needs of Global 2000 clients.

Investors were pleased when Answerthink reported earnings after the close on Tuesday. The company reported net revenues of $311.1 million, up 19% from last year and net income of $7.9 million, or $0.18 per diluted share, up from $1.1 million, or $0.03 per diluted share, in 1999. ANSR has reduced its exposure to dot-com projects, emerging as one of the most comprehensive and profitable consulting and systems integration providers. The move above the January high is encouraging and the improving technicals bode well for future upside activity.


MAR 7.50 QRA-CU LB=1.44 OI=3808 CB=6.65 DE=28 MR=13.9%  

 
 
Copyright 2000 - 2001 IRAInvestor.com

Do not duplicate or redistribute in any form.
Privacy Statement   Disclaimer   Terms Of Service